Recipharm laid out about $160 million to buy Italian CMO Corvette last year and now will plow additional money into one of the three Milan area plants it got…

For the second time this year, Teva has issued a recall of antibiotics produced at one of its facilities. This time it’s a plant in Canada.

The FDA, which has been on a campaign to get Indian drugmakers to conform with its regulations, slapped Unimark Remedies with another warning letter in which…

India’s Sun Pharma has had a host of problems at some of its own manufacturing facilities in India but it just narrowly escaped another warning letter for a…

The FDA recently issued another warning letter to Noven, a standalone operating subsidiary of Japan-based Hisamitsu Pharmaceuticals, for lapses at its Miami…

Sagent Pharmaceuticals ($SGNT) is widening its recall of antibiotics manufactured by one of its India-based contractors after a customer complained that small…

Sun Pharma continues to slog away at its remediation efforts at both its key plant in Halol as well at the four plants it got in its $4 billion buyout of…

A new report shows international regulators were unimpressed with Pfizer’s operations at a Hospira plant in India during a recent inspection.